Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A400EJ | ISIN: US45773H4092 | Ticker-Symbol: GBM
Tradegate
03.07.25 | 10:20
1,440 Euro
-20,44 % -0,370
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
INOVIO PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
INOVIO PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4001,42010:49
1,4001,42010:49

Aktuelle News zur INOVIO PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04:48INOVIO Pharma Announces Proposed Public Offering293WASHINGTON (dpa-AFX) - INOVIO Pharmaceuticals Inc. (INO) announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof)...
► Artikel lesen
MiInovio Pharmaceuticals stock plunges after announcing public offering5
INOVIO PHARMACEUTICALS Aktie jetzt für 0€ handeln
MiInovio Pharmaceuticals announces proposed public offering of common stock and warrants4
28.05.Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit38
22.05.Inovio-Aktionäre genehmigen Vorstandskandidaten und Anträge6
22.05.INOVIO PHARMACEUTICALS, INC. - 8-K, Current Report3
14.05.Oppenheimer cuts Inovio stock price target to $139
14.05.Inovio stock holds $12 target, JMP affirms Market Outperform4
14.05.Inovio outlines BLA submission timeline for INO-3107 and reports $68.4M cash position while advancing DNA medicine pipeline3
13.05.Inovio Pharmaceuticals GAAP EPS of -$0.51 beats by $0.231
13.05.INOVIO PHARMACEUTICALS, INC. - 8-K, Current Report1
13.05.INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights247On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)...
► Artikel lesen
13.05.INOVIO PHARMACEUTICALS, INC. - 10-Q, Quarterly Report1
19.03.Inovio aims for INO-3107 regulatory submission by mid-2025 while addressing key manufacturing issues20
19.03.Inovio stock price target cut to $12 by Citizens JMP38
18.03.INOVIO Pharmaceuticals, Inc.: INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights364Significant progress toward submitting a biologics license application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)...
► Artikel lesen
18.03.Inovio Pharmaceuticals Inc. Q4 Income Declines469WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) released a profit for fourth quarter that decreased from last yearThe company's bottom line came in at $19.4 million, or $0.65 per share....
► Artikel lesen
18.03.INOVIO PHARMACEUTICALS, INC. - 8-K, Current Report2
18.03.INOVIO PHARMACEUTICALS, INC. - 10-K, Annual Report3
17.03.Inovio Pharmaceuticals Q4 2024 Earnings Preview4
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1